Zoetis Inc. (ZTS)

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments. The company was founded in 1952 and is headquartered in Parsippany, NJ.

Address

10 SYLVAN WAY
PARSIPPANY, NJ 07054

Founded

1952

Number of Employees

14,100

Buyback

Buyback Data 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
$ Amount Purchased
($ in 000s )
$36 $202,455 $312,962 $510,722 $716,522 $659,174 $287,636 $814,569 $1,645,015 $1,106,187 $895,997 $650,116
Average Price $37.77 $45.89 $47.27 $60.25 $84.73 $107.38 $134.18 $183.33 $169.05 $172.22 $174.38 $115.37
# Shares Purchased 951 4,411,362 6,620,575 8,477,017 8,456,120 6,138,753 2,143,651 4,443,109 9,731,003 6,423,271 5,138,109 5,634,902
Buyback Performance 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
Total Return to Date 405.7% 316.2% 304.1% 217.0% 125.4% 77.9% 42.3% 4.2% 13.0% 10.9% 9.5% 65.5%
S&P 500 Return to Date 181.9% 173.0% 168.6% 129.7% 104.9% 93.1% 74.8% 31.7% 37.3% 31.3% 7.4% 94.0%
Excess Total Return 223.8% 143.2% 135.5% 87.3% 20.5% -15.2% -32.5% -27.5% -24.3% -20.4% 2.1% -28.4%
Quartile Rank
Percentile Rank 88% 86% 86% 84% 79% 70% 52% 49% 58% 50% 59% 76%
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.

Insider Transactions

Filters

Keyboard Shortcuts: Show (a) | Close (Esc)